V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008219 | 260005555 | 1.61 | 75 | Palliative (P) | 2016-09-13 | 2016-09-14 | CVP R | N | N | 260027458 | CVP R |
| 260008220 | 260005555 | 1.83 | null | Curative (C) | 2014-09-26 | 2014-09-30 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260027458 | BLEOMYCIN |
| 260008221 | 260005556 | 1.8 | 87 | Palliative (P) | 2013-12-11 | 2013-12-11 | Cisplatin + Etoposide (3 day) | 02 | N | 260027460 | RITUXIMAB |
| 260008222 | 260005556 | null | 67.1 | null | null | 2014-10-20 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | null | null | 260027460 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008223 | 260005556 | 1.63 | null | Disease modification (D) | 2016-09-29 | 2016-10-01 | Rituximab (Maintenance) | 01 | N | 260027460 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008224 | 260005557 | 1.74 | 110 | null | 2013-05-17 | 2013-05-19 | Rituximab | N | N | 260027465 | RITUXIMAB |
| 260008225 | 260005557 | 1.59 | null | Palliative (P) | 2014-07-20 | 2014-08-09 | Rituximab | N | N | 260027465 | CHLORAMBUCIL |
| 260008226 | 260015490 | 1.68 | null | Disease modification (D) | 2016-06-07 | 2016-10-20 | Rituximab | 2 | N | 260027468 | RITUXIMAB |
| 260008227 | 260005558 | 1.6 | 70 | Palliative (P) | 2013-11-15 | 2013-11-24 | CAPECITABINE + RT | N | N | 260027470 | RITUXIMAB |
| 260008228 | 260005558 | 1.7 | 61.95 | Disease modification (D) | 2017-09-06 | 2017-09-09 | EP 1 2 or 3 day | N | N | 260027470 | CISPLATIN + ETOPOSIDE |
| 260008229 | 260005558 | 1.74 | 85.2 | Curative (C) | 2014-06-29 | 2014-06-30 | Rituximab | 2 | N | 260027470 | TIP |
| 260008230 | 260005558 | 1.65 | null | null | 2017-02-01 | 2017-02-03 | Rituximab | 02 | null | 260027470 | CHOP |
| 260008231 | 260005559 | null | 62 | Unknown (U) | 2015-11-26 | 2015-12-03 | Bendamustine +/- Prednisolone | N | N | 260027476 | R-GEM-P |
| 260008232 | 260005559 | 1.64 | 102.4 | Not known (9) | 2017-04-24 | 2017-04-27 | Cisplatin + Etoposide (3 day) | 99 | null | 260027476 | CISPLATIN + ETOPOSIDE |
| 260008233 | 260005560 | null | 74 | Disease modification (D) | 2013-02-14 | 2013-02-14 | R Chlorambucil | 2 | N | 260027483 | RITUXIMAB |
| 260008234 | 260005561 | 1.71 | 66 | null | 2015-06-14 | 2015-06-24 | Rituximab | 2 | N | 260027484 | RITUXIMAB |
| 260008235 | 260005561 | null | null | Palliative (P) | 2018-01-05 | 2018-01-05 | Rituximab | 02 | N | 260027484 | RITUXIMAB |
| 260008236 | 260005561 | 1.55 | 55 | null | null | 2017-04-26 | Methotrexate intrathecal | null | null | 260027484 | RITUXIMAB |
| 260008237 | 260005562 | 1.6 | 54.9 | null | 2015-05-17 | 2015-05-17 | Rituximab | null | null | 260027487 | RITUXIMAB |
| 260008238 | 260005562 | 1.7 | 131 | null | 2015-11-07 | 2015-11-07 | Rituximab | null | N | 260027487 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 260008239 | 260005563 | 1.9 | 103 | Curative (C) | 2014-10-30 | 2014-11-01 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | 02 | N | 260027490 | CARBOPLATIN + ETOPOSIDE |
| 260008240 | 260005563 | 1.61 | 73 | Disease modification (D) | 2014-01-27 | 2014-02-04 | Cisplatin + Paclitaxel | 2 | N | 260027490 | CHLORAMBUCIL |
| 260008241 | 260005563 | null | 74.1 | null | 2014-11-17 | 2014-11-24 | Capecitabine + Cisplatin | N | N | 260027490 | RITUXIMAB |
| 260008242 | 260005563 | 1.76 | null | Curative (C) | 2017-12-06 | 2017-12-18 | Gemcitabine + Oxaliplatin | N | N | 260027490 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008243 | 260005564 | 1.71 | null | Palliative (P) | 2016-08-22 | 2016-09-14 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260027499 | CISPLATIN + ETOPOSIDE |
| 260008244 | 260011850 | 1.5 | 65.8 | Curative (C) | 2016-09-08 | 2016-09-13 | Rituximab | N | N | 260027500 | CISPLATIN + RT |
| 260008245 | 260005565 | 1.85 | 77 | Adjuvant (A) | 2018-04-13 | 2018-04-13 | Rituximab | 02 | N | 260027502 | NOT MATCHED |
| 260008246 | 260005565 | 1.71 | 90.3 | null | 2014-08-09 | 2014-08-22 | Cisplatin + Etoposide (3 day) | N | N | 260027502 | RITUXIMAB |
| 260008247 | 260005565 | 1.8 | 105 | Curative (C) | 2017-11-08 | 2017-11-16 | Rituximab | 2 | N | 260027502 | CHOP |
| 260008248 | 260005566 | 1.9 | 59.4 | Curative (C) | 2015-01-01 | 2015-01-01 | Cisplatin + Etoposide (3 day) | 2 | N | 260027509 | ETOPOSIDE |
| 260008249 | 260005566 | 1.8 | null | Palliative (P) | 2014-05-29 | 2014-05-29 | Rituximab | 01 | N | 260027509 | ABIRATERONE |
| 260008250 | 260005567 | 1.77 | 0 | Curative (C) | 2014-05-11 | 2014-05-29 | Capecitabine | N | N | 260027515 | RITUXIMAB |
| 260008251 | 260005567 | 1.69 | 78.8 | Disease modification (D) | 2013-07-10 | 2013-07-10 | Cyclophosphamide + Vincristine | 02 | N | 260027515 | RITUXIMAB |
| 260008252 | 260005567 | 1.8 | null | null | 2018-02-16 | 2018-03-03 | GC Int Guide Excranial GermCell JEB | 02 | N | 260027515 | BLEOMYCIN + VINCRISTINE |
| 260008253 | 260005567 | null | 86 | Curative (C) | 2015-11-19 | 2016-12-14 | ABVD | Y | N | 260027515 | CYTARABINE HIGH DOSE |
| 260008254 | 260005568 | 1.73 | 67.4 | Curative (C) | 2014-12-08 | 2014-12-08 | Chlorambucil + Pred + Rituximab | 02 | N | 260027525 | HYDROXYCARBAMIDE |
| 260008255 | 260005569 | 1.85 | null | Disease modification (D) | 2017-04-08 | 2017-04-28 | Trial Unspecified | N | N | 260027528 | RITUXIMAB |
| 260008256 | 260005569 | 1.81 | 0 | null | null | 2017-07-24 | ESHAP | null | null | 260027528 | CHOP |
| 260008257 | 260005570 | 1.7 | 69 | Disease modification (D) | 2015-12-03 | 2015-12-05 | Rituximab | N | N | 260027532 | RITUXIMAB |
| 260008258 | 260005570 | null | 0 | Disease modification (D) | 2018-01-18 | 2018-01-28 | Rituximab | N | N | 260027532 | RITUXIMAB |
| 260008259 | 260005571 | null | 86.06 | Curative (C) | 2016-01-03 | 2016-01-04 | BEAM | 2 | Y | 260027535 | RITUXIMAB |
| 260008260 | 260011856 | 1.7 | 57.2 | null | 2018-10-16 | 2018-10-16 | Rituximab (Maintenance) | 02 | null | 260027540 | RITUXIMAB |
| 260008261 | 260011856 | null | 80.8 | Curative (C) | null | 2013-08-02 | ABVD | null | null | 260027540 | MPV |
| 260008262 | 260005572 | 1.8 | null | Disease modification (D) | 2017-05-06 | 2017-05-08 | null | N | N | 260027542 | CHOP |
| 260008263 | 260005572 | null | 77.3 | Disease modification (D) | 2014-09-30 | 2014-10-02 | Bendamustine +/- Prednisolone | N | N | 260027542 | RITUXIMAB |
| 260008264 | 260005573 | 1.6 | null | Curative (C) | 2013-12-25 | 2013-12-25 | AML17 TRIAL | N | N | 260027545 | RITUXIMAB |
| 260008265 | 260005573 | 1.58 | 80.8 | Curative (C) | 2015-11-26 | 2015-11-26 | Bendamustine +/- Prednisolone | 02 | N | 260027545 | RITUXIMAB |
| 260008266 | 260005574 | null | 75 | Curative (C) | 2017-08-26 | 2017-08-29 | Rituximab | N | N | 260027547 | RITUXIMAB |
| 260008267 | 260005574 | null | 76.1 | Curative (C) | 2016-10-06 | 2016-10-07 | Rituximab | N | N | 260027547 | RITUXIMAB |
| 260008268 | 260005574 | null | 84.5 | Palliative (P) | 2015-06-28 | 2015-06-28 | Rituximab | null | N | 260027547 | RITUXIMAB |